Oberweis Asset Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-217,992
Closed -$8.62M 181
2025
Q4
$8.62M Buy
217,992
+64,492
+42% +$2.36M 0.32% 117
2025
Q3
$5.41M Buy
+153,500
New +$5.29M 0.21% 143
2025
Q2
Sell
-151,500
Closed -$4.89M 186
2025
Q1
$4.89M Hold
151,500
0.24% 131
2024
Q4
$4.63M Buy
+151,500
New +$4.87M 0.22% 146
2024
Q1
Sell
-69,100
Closed -$2.47M 196
2023
Q4
$2.47M Buy
69,100
+21,800
+46% +$811K 0.23% 158
2023
Q3
$2.07M Buy
+47,300
New +$2.31M 0.22% 154
2019
Q4
Sell
-139,600
Closed -$3.48M 201
2019
Q3
$3.48M Sell
139,600
-65,350
-32% -$1.87M 0.79% 32
2019
Q2
$6.12M Buy
204,950
+1,540
+0.8% +$45K 1.11% 20
2019
Q1
$5.45M Sell
203,410
-27,710
-12% -$842K 1.09% 24
2018
Q4
$7.07M Sell
231,120
-7,090
-3% -$221K 1.58% 12
2018
Q3
$8.34M Buy
238,210
+11,291
+5% +$357K 1.62% 16
2018
Q2
$6.14M Buy
+226,919
New +$5.33M 1.54% 20
2016
Q1
Sell
-25,500
Closed -$572K 177
2015
Q4
$572K Buy
25,500
+2,400
+10% +$49.5K 0.16% 106
2015
Q3
$506K Buy
23,100
+3,500
+18% +$87.5K 0.15% 92
2015
Q2
$483K Hold
19,600
0.13% 97
2015
Q1
$402K Sell
19,600
-18,400
-48% -$356K 0.11% 115
2014
Q4
$758K Hold
38,000
0.23% 66
2014
Q3
$559K Buy
38,000
+1,800
+5% +$28.7K 0.15% 78
2014
Q2
$665K Buy
+36,200
New +$603K 0.16% 97

Other funds holding ATRC

Oberweis Asset Management's ATRC Position: Q1 2026 in Review

Oberweis Asset Management sold out of AtriCure (ATRC) in Q1 2026, closing a stake of 217,992 shares — an estimated $8.62M sold.

Oberweis Asset Management first reported a position in ATRC in Q2 2014 and held it in 19 quarters. The position peaked at $8.62M in Q4 2025. 223 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.

  • Oberweis Asset Management reported no remaining AtriCure position as of Q1 2026 after selling out during the quarter.
  • Oberweis Asset Management sold 217,992 AtriCure shares in Q1 2026, an estimated $8.62M.
  • Oberweis Asset Management first reported a position in AtriCure in Q2 2014 and held it in 19 quarters.
  • Oberweis Asset Management's AtriCure position peaked at $8.62M in Q4 2025.
  • 223 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.

Based on Oberweis Asset Management's 13F filing for Q1 2026, filed 15 May 2026.